Melinta Therapeutics, LLC

Melinta Therapeutics, LLC, a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It offers KIMYRSA (oritavancin), a lipoglycopeptide antibiotic; Orbactiv, an IV antibiotic of the lipoglycopeptide class for the treatment of adult patients with ABSSSIs; Vabomere, an IV antibiotic used in the treatment of gram-negative infections; Minocin, an IV antibiotic of the tetracycline class with activity against gram-positive and gram-negative pathogens; and Baxdela, a monotherapy treatment of adult patients with acute bacterial skin or skin structure infections (ABSSSIs). The company was founded in 2000 and is based in Parsippany, New Jersey with an additional office in Lincolnshire, Illinois.